Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities

• Published in: European journal of medicinal chemistry 2021-06, Vol.218, p.113360-113360, Article 113360
• Main Authors: Elbadawi, Mostafa M., Eldehna, Wagdy M., Nocentini, Alessio, Abo-Ashour, Mahmoud F., Elkaeed, Eslam B., Abdelgawad, Mohamed A., Alharbi, Khalid S., Abdel-Aziz, Hatem A., Supuran, Claudiu T., Gratteri, Paola, Al-Sanea, Mohammad M.
• Format: Article
• Language: English
• Subjects: Benzenesulfonamide; Carbonic anhydrase inhibitors; Carboxylic acids; SLC-0111 analogues; Sulfones; Tail approach
• ISSN: 0223-5234; 1768-3254
• DOI: 10.1016/j.ejmech.2021.113360

As a front-runner selective CA IX inhibitor currently in Phase Ib/II clinical trials, SLC-0111 has been herein exploited as a lead molecule for development of new different sets of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides incorporating different functionalities; primary sulfonamide (5a-f), free carboxylic (8a, 8d), ethyl ester (8b, 8e), acetyl (8c, 8f) and nitro (10a, 10b), as potential carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. All the prepared analogues have been examined for their CA inhibitory activities towards four human (h) isoenzymes, hCA I, II, IX and XII. Interestingly, replacement of SLC-0111 ureido linker with the flexible sulfonyl acetamide linker, as well as linker branching and elongation strategies successfully enhanced the inhibitory action toward hCA IX isoform, such as in sulfones 5a-d and 5f which displayed better activity than SLC-0111. Furthermore, sulfonamide-based sulfone (5f) and carboxylic acid-based sulfones (8a and 8d) demonstrated interesting selectivity toward the tumor-related hCA IX isoform over both hCA I and hCA II, which suggests them as promising candidates for further development as potential anticancer candidates. Thereafter, the anti-proliferative action for sulfones 5f, 8a and 8d was examined against breast (MCF-7) and colon (HCT-116) cancer cell lines. Also, sulfone 5f was further assessed for its impact on the cell cycle progression and apoptosis in HCT-116 cells. [Display omitted] •New series of SLC-0111 analogues were designed and synthesized as potential CA inhibitors.•Inhibitory activities of all analogues were evaluated toward hCA I, II, IX and XII isoforms.•CA IX and XII were efficiently inhibited with KIs range: 4.3–46.1 and 5.1–42.4 nM, respectively.•Sulfones 5a-d and 5f displayed better CA IX inhibitory activity than the lead SLC-0111.•Sulfonamide 5f and carboxylic acids 8a and 8d demonstrated interesting hCA IX/II selectivity.